Compare Canadian Natural Resources Ltd. (CNQ) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Canadian Natural Resources Ltd. vs Regeneron Pharmaceuticals Inc — how do they compare? Canadian Natural Resources Ltd. trades at $47.07 (market cap $97.27B), while Regeneron Pharmaceuticals Inc trades at $796.38 (market cap $83.19B). The key difference: Canadian Natural Resources Ltd. is the larger of the two by market cap, and Canadian Natural Resources Ltd. pays the higher dividend (3.76%). Which is the better fit depends on your goals.
| CNQ | REGN | |
|---|---|---|
Market Cap | $97.27B | $83.19B |
Sector | Energy | Health |
52-Week High | $50.55 | $812.27 |
52-Week Low | $29.31 | $555.51 |
Enterprise Value | $107.68B | $77.90B |
Dividend Yield | 3.76% | 0.47% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Canadian Natural Resources Ltd.
Canadian Natural Resources is one of the largest oil and natural gas producers in western Canada, supplemented by operations in the North Sea and Offshore Africa. The company's portfolio includes light and medium oil, heavy oil, bitumen, synthetic oil, natural gas liquids, and natural gas. Production averaged 1.16 million barrels of oil equivalent per day in 2020, and the company estimates that it holds over 11.5 billion boe of proven and probable crude oil and natural gas reserves.
Read more on CNQ →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
